SNYNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SNYNF
Sanofi
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 17, 2026
$39.57−1.04 (-2.56%)
Close on Oct 19, 2026
Sanofi statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Income (trailing twelve months)
| Measure | Sanofi | Industry median |
|---|---|---|
| Gross Profit | €33.67B | €1.08B |
| Operating Income | €6.34B | -€68.03M |
| Net Income | €7.81B | -€6.53M |
| EBITDA | €6.34B | -€48.04M |
| EPS (Diluted) | 6.37 EUR | -0.61 EUR |
Returns
| Measure | Sanofi | Industry median |
|---|---|---|
| Return on Equity (ROE) | 10.5% | 2.67% |
| Return on Assets (ROA) | 6.02% | -5.10% |
| Return on Invested Capital (ROIC) | 5.95% | |
| Return on Capital Employed (ROCE) | 6.44% | -26.9% |
Growth
| Measure | Sanofi | Industry median |
|---|---|---|
| Net Income Growth (YoY) | 40.5% | |
| EPS Growth (YoY) | 43.8% | 67.4% |
| EPS Growth (3Y CAGR) | -1.47% | |
| EPS Growth (5Y CAGR) | -8.20% |
Balance sheet
| Measure | Sanofi | Industry median |
|---|---|---|
| Cash & Short-Term Investments | €7.66B | €291.68M |
| Total Debt | €18.59B | €496.91M |
| Net Cash (Debt) | -€10.93B | €87.54M |
| Net Cash Per Share | -8.97 EUR | 1.09 EUR |
| Equity (Book Value) | €71.38B | €952.53M |
| Book Value Per Share | 58.53 EUR | 5.36 EUR |
| Tangible Book Value | €3.82B | €21.84M |
| Working Capital | €2.61B | €121.78M |
Financial position
| Measure | Sanofi | Industry median |
|---|---|---|
| Current Ratio | 1.09 | 2.81 |
| Quick Ratio | 0.57 | 1.23 |
| Debt / Equity | 0.26 | |
| Debt / EBITDA | 2.93 | |
| Net Debt / EBITDA | 1.72 | |
| Interest Coverage | 11.27 | -0.90 |
Cash flow (trailing twelve months)
| Measure | Sanofi | Industry median |
|---|---|---|
| Operating Cash Flow | €10.75B | -€35.31M |
Efficiency
| Measure | Sanofi | Industry median |
|---|---|---|
| Inventory Turnover | 1.33 | 1.33 |
| Profits Per Employee | €842.46K | -€247.02K |
| Employee Count | 9,274 | 378 |
Shares
| Measure | Sanofi | Industry median |
|---|---|---|
| Shares Outstanding | 1,219,430,000 | 105,361,000 |
| Shares Change (YoY) | -2.43% | 6.28% |
| Float | 1,219,430,000 | 78,574,400 |
| Shares Held by Insiders | 0.00% | 9.05% |
| Shares Held by Institutions | 15.5% | 13.8% |
Taxes
| Measure | Sanofi | Industry median |
|---|---|---|
| Income Tax | €1.04B | €1.53M |
Scores
| Measure | Sanofi | Industry median |
|---|---|---|
| Graham Number | 91.59 EUR | |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from Sanofi's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.